Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 SAD of Vocacapsaicin in Bunionectomy
NCT03307837Phase 1Completed
- Sponsor
- Concentric Analgesics, Inc.
- Start
- Nov 2017
- Primary completion
- Mar 2018
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of vocacapsaicin in postoperative pain (6 arms), sponsored by Concentric Analgesics, Inc. Primary endpoints: Surgical Site Assessment at 48 hours and Neurosensory Assessment at 48 hours. Started Nov 2017; status: completed.
02
Drugs
vocacapsaicin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03307837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03307837.